TICLOPIDINE HYDROCHLORIDE Drug Patent Profile
When do Ticlopidine Hydrochloride patents expire, and what generic alternatives are available?
Ticlopidine Hydrochloride is a drug marketed by Actavis Elizabeth, Apotex, Chartwell Rx, Mylan, Natco Pharma, Sun Pharm Inds Inc, Teva, and Watson Labs. and is included in nine NDAs.
The generic ingredient in TICLOPIDINE HYDROCHLORIDE is ticlopidine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the ticlopidine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TICLOPIDINE HYDROCHLORIDE?
- What are the global sales for TICLOPIDINE HYDROCHLORIDE?
- What is Average Wholesale Price for TICLOPIDINE HYDROCHLORIDE?
Summary for TICLOPIDINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Clinical Trials: | 39 |
| DailyMed Link: | TICLOPIDINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TICLOPIDINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ain Shams University | Phase 3 |
| Kafrelsheikh University | Phase 3 |
| Janssen Research & Development, LLC | Phase 1 |
Medical Subject Heading (MeSH) Categories for TICLOPIDINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TICLOPIDINE HYDROCHLORIDE
US Patents and Regulatory Information for TICLOPIDINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Elizabeth | TICLOPIDINE HYDROCHLORIDE | ticlopidine hydrochloride | TABLET;ORAL | 075253-001 | Aug 20, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm Inds Inc | TICLOPIDINE HYDROCHLORIDE | ticlopidine hydrochloride | TABLET;ORAL | 075526-001 | Sep 26, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | TICLOPIDINE HYDROCHLORIDE | ticlopidine hydrochloride | TABLET;ORAL | 075326-001 | Aug 20, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | TICLOPIDINE HYDROCHLORIDE | ticlopidine hydrochloride | TABLET;ORAL | 075149-001 | Aug 20, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
